Legislative Panorama: Focus On Netherlands

Abstract Access to medical cannabis in the Netherlands has been limited, despite its availability as a prescription drug since 2003. The National Health Institute’s reluctance to officially recognize medical cannabis as a treatment has resulted in increased costs through official channels. Consequently, there has been a significant decline in medical cannabis prescriptions, and the number […]

Legislative Panorama: Focus On Portugal

Since 2018, medical cannabis has been legal in Portugal, but only one pharmaceutical company, Tilray, has been approved by Infarmed, the regulatory agency responsible for approving medical cannabis products in the country. Medical cannabis use in Portugal is limited to cases where conventional treatments are ineffective or cause adverse effects, and the therapeutic indication has […]

Legislative Panorama: Focus On Switzerland

Switzerland’s CBD and medical cannabis industry is currently valued at an estimated EUR 75 million, a figure expected to more than double as regulated medical and adult-use cannabis consumption picks up. Since August 2022, Swiss physicians can prescribe medical cannabis to patients without limitations. Switzerland’s move toward making adult-use and medical-use cannabis accessible is likely […]

March is Endometriosis Awareness Month!

Every March, the world observes Endometriosis Awareness Month to raise awareness and support millions of women affected by Endometriosis around the globe.  Endometriosis impacts the lives of hundreds of women living with the condition, disrupting their lives as they endure unbearable pain among a plethora of symptoms that significantly degrade their quality of life. Women […]